Alantolactone induces platelet apoptosis by activating the Akt pathway.
Platelets
; 34(1): 2173505, 2023 Dec.
Article
em En
| MEDLINE
| ID: mdl-36813739
What is the context? In the past several decades, natural products, including traditional Chinese medicine (TCM), have been developed for the treatment of a variety of diseases.Alantolactone (ALT), a natural herb compound mainly extracted from the root of Inula helenium L., is the essential active component in many TCM formulas. ALT has attracted extensive attention because of its anti-cancer capacity recently.However, adverse events (AEs) induced by drugs are common in chemotherapy, and the side effects of ALT treatment remain unclear.What is new? In this study, experiments were conducted to clarify the precise effect of ALT on platelets. We demonstrated for the first time that ALT induces platelet apoptosis and platelet count decline, suggesting possible side effects of ALT treatment.ALT-activated Akt elicited platelet apoptosis by activating phosphodiesterase (PDE3A) and PDE3A-mediated protein kinase A (PKA) inhibition.Our work provides experimental evidence supporting the hypothesis that the effects of ALT on Akt may vary depending on cell types. Therefore. More research is needed to explore the side effects of ALT on other cells before clinical application.What is the impact? This study reveals possible side effects of ALT treatment, providing the reference for clinic drug administrate and estimation of medicine safety. Significantly, our findings demonstrated relevant molecular mechanisms, providing strategies for controlling or alleviating these side effects in the future.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fosfatidilinositol 3-Quinases
/
Proteínas Proto-Oncogênicas c-akt
Tipo de estudo:
Prognostic_studies
Limite:
Animals
Idioma:
En
Revista:
Platelets
Assunto da revista:
HEMATOLOGIA
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China
País de publicação:
Reino Unido